Exelixis, Inc. (EXEL) vs Zimmer Biomet Holdings, Inc. (ZBH)
A side-by-side comparison of Exelixis, Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.
EXEL
Exelixis, Inc.
$59.13HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT
ZBH
Zimmer Biomet Holdings, Inc.
$98.91HealthcareDelayed quote: Sep 3, 2026, 3:55 PM EDT
Total return — EXEL vs ZBH
growth of $100 · dividends reinvested · last 10yEXEL +434.0% (+18.2%/yr)ZBH -14.0% (-1.5%/yr)EXEL compounded faster over this window
Log scale — wide-divergence pair
EXEL ZBH
EXEL vs ZBH: by the numbers
- •ZBH is the larger company ($19.13B vs $14.86B market cap).
- •EXEL trades at the lower trailing earnings multiple (18.35 vs 24.21 P/E), one valuation lens rather than an overall verdict.
- •EXEL converts more revenue to profit (35.33% vs 9.48% net margin).
- •EXEL grew revenue faster over the past five years (16.06% vs 2.89% CAGR).
- •ZBH pays a dividend (0.96% yield), while EXEL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EXEL | ZBH |
|---|---|---|
| P/E ratio | 18.35 | 24.21 |
| Forward P/E | 19.63 | 11.66 |
| P/S ratio | 6.24 | 2.25 |
| P/B ratio | 8.24 | 1.52 |
| EV / EBITDA | 15.09 | 11.22 |
| FCF yield | 7.77% | 9.54% |
Profitability
| Metric | EXEL | ZBH |
|---|---|---|
| Gross margin | 96.48% | 61.62% |
| Operating margin | 39.88% | 15.73% |
| Net margin | 35.33% | 9.48% |
| ROE | 46.68% | 6.39% |
| ROIC | 37.87% | 5.51% |
Dividends
| Metric | EXEL | ZBH |
|---|---|---|
| Dividend yield | N/A | 0.96% |
| Payout ratio | N/A | 26.97% |
Growth (annualized)
| Metric | EXEL | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 16.06% | 2.89% |
| EPS CAGR (5Y) | 51.51% | N/A |
| FCF CAGR (5Y) | 40.17% | 6.49% |
| Total return CAGR (5Y) | 23.63% | -6.41% |
Frequently asked
- Which has the lower trailing P/E, EXEL or ZBH?
- EXEL has the lower trailing P/E: EXEL trades at 18.35 and ZBH at 24.21. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, EXEL or ZBH?
- Over the past five years, EXEL grew revenue faster — EXEL at a 16.06% CAGR versus ZBH at 2.89%.
- Does EXEL or ZBH pay a bigger dividend?
- ZBH pays a dividend (0.96% yield), while EXEL has no payments in the available dividend history.
- Is EXEL or ZBH more profitable?
- EXEL runs the higher net margin — EXEL at 35.33% versus ZBH at 9.48%.
- How have EXEL and ZBH total returns compared?
- Over the past 10 years, EXEL delivered 17.63% and ZBH delivered -1.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Exelixis P/E ratioZimmer Biomet P/E ratioZimmer Biomet dividend yieldExelixis ROEZimmer Biomet ROEExelixis operating marginZimmer Biomet operating marginExelixis revenue growthZimmer Biomet revenue growthExelixis free cash flowZimmer Biomet free cash flow
Exelixis & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.